Ontada

Ontada is an oncology-focused and insights business dedicated to transforming cancer care. As part of McKesson Corporation, Ontada leverages real-world data and evidence, clinical education, and provider technology to accelerate innovation and improve patient outcomes in oncology. The company's core offerings include real-world data solutions for life sciences companies, clinical and operational technology for community oncology providers, and educational programs for healthcare professionals.

Ontada's flagship product is iKnowMed, an electronic health record (EHR) system for research and analysis. The company also offers Practice Insights, a performance analytics tool that enables oncology practices to assess their performance across various value-based care initiatives. In February 2024, Ontada's Practice Insights was designated as a Qualified Clinical Data Registry by the Centers for Medicare & Medicaid Services, allowing efficient data submission for the Merit-based Incentive Payment System.

In October 2023, Ontada was awarded a contract by the US FDA to study the natural history of rare cancers in the community oncology setting. This research aimed to enhance understanding of how patients with rare cancers are diagnosed and treated.

Key customers and partnerships

Ontada works closely with The US Oncology Network, a large network of independent community oncology practices. The partnership allows Ontada to access vast real-world oncology data and collaborate with community oncologists on various research initiatives.

In November 2024, Ontada partnered with health data platform Datavant to improve access to oncology research data. The collaboration enabled researchers to connect Ontada's data with other datasets through Datavant's secure health data ecosystem, accelerating oncology innovation and drug development.

In October 2024, the company partnered with Microsoft to process unstructured oncology data using Azure AI. The partnership also leveraged Ontada's ON.Genuity platform, combining AI with a common data model to generate real-world data from its iKnowMed EHR.

In August 2022, Ontada also entered a strategic alliance with BeiGene, a global biotechnology company, to improve US community oncology care. The partnership focuses on developing real-world evidence data, tools, and insights to increase access to affordable cancer therapies.